Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The scaffold attachment factor B pseudogene (ENSG00000254935) is a processed pseudogene in the human genome with sequence homology to the active scaffold attachment factor B gene. Processed pseudogenes arise from reverse transcription of mRNA followed by reintegration into the genome, lack introns, and are generally incapable of generating functional proteins. This pseudogene retains sequence similarity but does not encode an active protein nor participate in typical biological processes and has no established relevance as a therapeutic target. It is generally classified as noncoding “junk DNA” but may be transcribed at low levels; however, there is no evidence that ENSG00000254935 plays a functional biological, pathological, or pharmacological role. If your intent is to study scaffold attachment factor B (SAFB, a functional DNA/RNA-binding nuclear matrix protein), please note that ENSG00000254935 does not encode this protein but represents an inactive copy.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Scaffold attachment factor B pseudogene.